Navigation Links
Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day on October 1

INDIANAPOLIS, Sept. 28, 2011 /PRNewswire/ -- As part of its ongoing work in the prevention and control of serious infections in healthcare settings, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today its sponsorship of the 3rd Annual World MRSA Day. The kick-off event and global MRSA summit will be held on October 1, 2011, at Loyola University Stritch School of Medicine in Maywood, Ill.

Organized by the MRSA Survivors Network, World MRSA Day highlights the importance of a comprehensive approach to controlling MRSA (methicillin-resistant Staphylococcus aureus), a type of bacterium that is resistant to common antibiotics and can cause serious infections. High rates of infection and mortality and high costs of treatment due to healthcare-associated infections (HAIs) caused by MRSA are a critical issue for healthcare facilities worldwide. The goal for the event is to raise widespread awareness of the need for greater MRSA prevention, screening, treatment and education.

"Roche applauds the MRSA Survivors Network for bringing this important issue to the forefront and we are honored to be a sponsor of World MRSA Day," said Jack Phillips, president and CEO of Roche Diagnostics Corporation. "Healthcare-associated infections caused by MRSA are preventable, and we believe that more education, together with effective screening and infection control programs, can significantly reduce the spread of MRSA and its consequences."

The kick-off event, which features MRSA expert and former CDC scientist William R. Jarvis, M.D., as keynote speaker, will be broadcast live via web stream starting at 10:30 a.m. central time on Oct. 1 and can be viewed at and

About HAIs and MRSA screening

Healthcare-associated infections (HAIs) caused by MRSA are a tremendous burden for healthcare systems and hospitals and are associated with significant healthcare costs. The Centers for Disease Control and Prevention (CDC) has estimated that approximately 18,000 persons die of invasive MRSA HAIs in U.S. healthcare facilities annually – more than from HIV/AIDS – underscoring the need for comprehensive infection control programs, along with more rapid and reliable MRSA screening methods. In response to this public health issue, an increasing number of states have passed legislation requiring mandatory reporting and/or screening for HAIs.  

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: or

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:
Betsy Cox
Director, Corporate Communications
Roche Diagnostics Corporation
Indianapolis, IN
(317) 521-3911

SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Overtakes GSK but Trails Roche in PharmaDeals Corp-METRx Analysis of Deal Activity
2. Roche Starts Early Stage Clinical Trial in Down Syndrome
3. Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4
4. Rochester Medical Reports Fiscal 2011 Third Quarter Results
5. Rochester Medical Announces Third Quarter 2011 Earnings Conference Call Thursday, July 28, 2011
6. Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
7. In Support of the International Day of the African Child, Roche Hosts Annual Childrens Walk
8. Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date
9. Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic
10. Florida Hospital First U.S. Site to Adopt New Automated Laboratory Solution From Roche
11. Roche Symposium Showcases Accomplishments of Next Generation of Chemists
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):